跳至主要内容
临床试验/IRCT20210724051972N1
IRCT20210724051972N1已完成2 期

Investigation of the effectiveness of anti-anxiety medication (Buspirone and Mirtazapine) on anxiety and gastrointestinal symptoms of functional dyspepsia patients with postprandial discomfort syndrome

Birjand University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • Willingness to participate in the study after explaining all the objectives of the research and the advantages and disadvantages of the methods
  • Failure to receive psychological treatment before entering the study
  • Lack of other structural or functional gastrointestinal disorders
  • No other organic disease
  • Possibility to keep the type and amount of drug used during the research period if the drug is used
  • No alcohol and drugs
  • No psychotic disorder and personality disorder
  • Absence of alarm signs such as gastrointestinal bleeding, blood in the stool, fever, weight loss, anemia, nocturnal diarrhea, severe heartburn
  • Age between 18 and 50 years

排除标准

  • 未提供

研究者

相似试验